Genomic Medicine is making a rapid entry into the healthcare landscape, but questions on the potential vs realized impacts toward clinical care outcomes persist. Which genomic information will be crucial to patient care? Addressing this and other questions with host Dr. Howard Levy is Dr. Robert Green, Director of the Genes-2-People (G2P) Research Program in Translational Genomics and Health Outcomes at Brigham and Women's Hospital and Harvard Medical School.
